← SynDRA
MEZIGDOMIDE
SynDRA canonical compound SYN0040098 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | CRBN |
|---|
| Mechanism of action | ubiquitin ligase inhibitor |
|---|
| Indication | multiple myeloma |
|---|
| Disease area | hematologic malignancy |
|---|
All known targets
Mechanisms of action (all sources)
- ubiquitin ligase inhibitor
Cross-references
Synonyms
- CC-92480
- CC92480
- CPD. 3(CC-92480)
- MEZIGDOMIDE (CC-92480)
- CELMoD
- CC 92480
- Mezigdomide [USAN]
- LA88IH4O02
- MEZIGDOMIDE [INN]
- compound 4 [PMID: 32130004]
- compound 4 (PMID: 32130004)
- RefChem:158446
- CELMoD CC-92480
- Cereblon Modulator CC-92480
- BMS986348
- BMS-986348
- Cereblon E3 Ligase Modulation Drug CC-92480
- Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480
- UNII-LA88IH4O02
- WHO 11455
- QFC
- Mezigdomide [WHO-DD]
- Mezigdomide (JAN/USAN)
- orb1309864
- SCHEMBL20608563
- SCHEMBL29370160
- SCHEMBL29520046
- C32H30FN5O4
- GTPL12718
- YQF2526
- GLXC-22274
- EX-A5597
- EBC-84030
- MFCD32263041
- NSC853698
- s8975
- AKOS040732735
- AT18067
- NSC-853698
Look up MEZIGDOMIDE in the interactive SynDRA portal →